Amphastar Pharmaceuticals, Inc. (AMPH)
26.78
-0.22
(-0.81%)
USD |
NASDAQ |
Dec 31, 16:00
26.78
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Cash from Investing (Quarterly): -19.62M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly & Co. | -2.983B |
| Align Technology, Inc. | -19.76M |
| Ionis Pharmaceuticals, Inc. | 91.34M |
| CorMedix, Inc. | -291.32M |
| Supernus Pharmaceuticals, Inc. | 48.71M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 52.58M |
| Cash from Financing (Quarterly) | -4.347M |
| Free Cash Flow | 111.00M |
| Free Cash Flow Per Share (Quarterly) | 0.9907 |
| Free Cash Flow to Equity (Quarterly) | 45.96M |
| Free Cash Flow to Firm (Quarterly) | 52.30M |
| Free Cash Flow Yield | 8.42% |